Target Price | $135.09 |
Price | $98.68 |
Potential |
36.90%
register free of charge
|
Number of Estimates | 21 |
21 Analysts have issued a price target BioNTech SE - ADR 2026 .
The average BioNTech SE - ADR target price is $135.09.
This is
36.90%
register free of charge
$171.42
73.72%
register free of charge
$109.44
10.90%
register free of charge
|
|
A rating was issued by 25 analysts: 19 Analysts recommend BioNTech SE - ADR to buy, 6 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the BioNTech SE - ADR stock has an average upside potential 2026 of
36.90%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 3.13 | 2.26 |
27.96% | 27.59% | |
EBITDA Margin | -31.29% | -75.79% |
209.49% | 142.22% | |
Net Margin | -24.18% | -61.85% |
199.27% | 155.76% |
19 Analysts have issued a sales forecast BioNTech SE - ADR 2025 . The average BioNTech SE - ADR sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an BioNTech SE - ADR EBITDA forecast 2025. The average BioNTech SE - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 BioNTech SE - ADR Analysts have issued a net profit forecast 2025. The average BioNTech SE - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.15 | -5.84 |
172.25% | 85.40% | |
P/E | negative | |
EV/Sales | 2.22 |
9 Analysts have issued a BioNTech SE - ADR forecast for earnings per share. The average BioNTech SE - ADR EPS is
This results in the following potential growth metrics and future valuations:
BioNTech SE - ADR...
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 22 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | May 22 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 14 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | May 06 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | May 06 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 22 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
May 22 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 14 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
May 06 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
May 06 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 01 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Mar 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.